Thursday, June 27, 2019 11:15:05 AM
Recent NBY News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/29/2024 12:19:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 12:15:10 PM
- NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC • Business Wire • 10/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:27:16 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 10/16/2024 08:19:35 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/25/2024 09:17:41 PM
- Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm • PR Newswire (US) • 09/23/2024 01:27:00 PM
- Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals • PR Newswire (US) • 09/20/2024 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/20/2024 12:08:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:08:15 PM
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets • Business Wire • 09/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:11:02 PM
- NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results • Business Wire • 08/13/2024 08:05:00 PM
- NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 • Business Wire • 08/01/2024 10:50:00 AM
- NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales • Business Wire • 07/30/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:25:15 PM
- NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option • Business Wire • 07/29/2024 08:05:00 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 07/26/2024 09:19:56 PM
- NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering • Business Wire • 07/26/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/26/2024 04:15:03 AM
- NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day • Business Wire • 07/16/2024 10:50:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/11/2024 12:50:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 12:45:30 PM
- NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million • Business Wire • 07/11/2024 10:50:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/10/2024 08:05:39 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM